Overall, given the relatively low usage of GLP-1 RAs in the UK and Europe, further clinical evidence and prescribing guidance may be beneficial to encourage the optimised use of GLP-1 RAs
Zhou L, Qu H, Yang L, Shou L
Comparative studies on succinate and alpha-glycerophosphate dehydrogenase with special reference to putatively glutamatergic structures

Water, Cyclopentasiloxane, Titanium Dioxide, Propanediol, C12-15 Alkyl Benzoate, Cyclohexasiloxane, Glycerin, Niacinamide, Polysorbate 60, Cetearyl Olivate, 1,2-Hexanediol,Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer, Squalane, Butyrospermum Parkii (Shea) Butter, Sodium Hyaluronate, Sorbitan Olivate, Cetearyl Alcohol, Cetearyl Glucoside, Glutathione, Oxygen, Malva Sylvestris (Mallow) Extract, Mentha Piperita (Peppermint) Leaf Extract, Primula Veris Extract, Alchemilla Vulgaris Extract, Veronica Officinalis Extract, Melissa Officinalis Leaf Extract, Achillea Millefolium Extract, Alcohol, Tocopheryl Acetate, Panthenol, Allantoin, Aluminum Hydroxide, Stearic Acid, Dimethiconol, Dimethicone, Dimethicone/Vinyl Dimethicone Crosspolymer, Laureth-23, Butylene Glycol, Sodium Polyacrylate, Hydrogenated Polydecene, Trideceth-6, Decylene Glycol, Caprylyl Glycol, Pentylene Glycol, Sorbitan Isostearate, Chlorphenesin, Ethylhexylglycerin, Citrus Aurantium Bergamia (Bergamot) Fruit Oil, Citrus Aurantium Dulcis (Orange) Oil
